Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Chun-Yang Fan

Concepts (278)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
14
2010
292
1.580
Why?
Carcinoma, Squamous Cell
15
2010
332
1.500
Why?
DNA Methylation
13
2009
592
1.010
Why?
DNA Glycosylases
5
2011
19
0.950
Why?
Promoter Regions, Genetic
11
2009
465
0.940
Why?
Gene Silencing
7
2009
122
0.940
Why?
DNA Repair
5
2008
197
0.450
Why?
Mitochondria
3
2011
447
0.450
Why?
Polymerase Chain Reaction
11
2009
452
0.430
Why?
Adaptor Proteins, Signal Transducing
5
2009
202
0.430
Why?
Kidney Neoplasms
2
2008
181
0.420
Why?
DNA, Neoplasm
10
2008
146
0.410
Why?
Nuclear Proteins
5
2009
250
0.410
Why?
Carcinoma, Non-Small-Cell Lung
2
2007
175
0.410
Why?
Neoplasm Proteins
4
2005
330
0.370
Why?
Laryngeal Neoplasms
3
2007
44
0.350
Why?
Vascular Endothelial Growth Factor A
2
2009
189
0.330
Why?
CpG Islands
3
2008
114
0.330
Why?
Lung Neoplasms
2
2007
645
0.310
Why?
Microsatellite Instability
1
2009
21
0.300
Why?
Immunohistochemistry
7
2012
975
0.300
Why?
Fatty Liver
1
2011
145
0.300
Why?
Mitochondrial Proteins
2
2007
90
0.290
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
26
0.280
Why?
Port-Wine Stain
1
2008
14
0.280
Why?
Oxygen
1
2011
338
0.280
Why?
O(6)-Methylguanine-DNA Methyltransferase
2
2005
9
0.270
Why?
Lymph Nodes
2
2007
252
0.270
Why?
Genes, p16
3
2005
9
0.260
Why?
DNA, Mitochondrial
4
2011
116
0.260
Why?
Skin
3
2010
420
0.260
Why?
N-Glycosyl Hydrolases
1
2007
6
0.260
Why?
Carcinoma, Renal Cell
1
2008
112
0.260
Why?
DNA-(Apurinic or Apyrimidinic Site) Lyase
1
2007
15
0.250
Why?
Adenoma
1
2008
114
0.250
Why?
Mitochondria, Liver
1
2007
69
0.250
Why?
Aged
15
2011
10430
0.250
Why?
Cisplatin
3
2007
282
0.240
Why?
Proteoglycans
2
2003
86
0.240
Why?
Fibroma
1
2006
41
0.230
Why?
Liver
1
2011
1150
0.220
Why?
Aged, 80 and over
8
2009
3495
0.220
Why?
Membrane Glycoproteins
2
2003
238
0.220
Why?
Survival Analysis
5
2009
659
0.220
Why?
Middle Aged
16
2011
13422
0.210
Why?
Carcinoma, Hepatocellular
1
2007
213
0.210
Why?
Humans
36
2013
53246
0.210
Why?
Prognosis
7
2007
2118
0.210
Why?
DNA Repair Enzymes
1
2004
44
0.210
Why?
Ataxia Telangiectasia
1
2004
7
0.200
Why?
Salivary Ducts
1
2003
3
0.200
Why?
Salivary Gland Neoplasms
1
2003
8
0.200
Why?
Adenocarcinoma, Clear Cell
1
2003
35
0.200
Why?
Receptors, Cytoplasmic and Nuclear
1
2003
65
0.200
Why?
Liver Neoplasms
1
2007
347
0.190
Why?
Obesity
1
2011
1205
0.180
Why?
Adult
14
2011
14541
0.180
Why?
Nitric Oxide Synthase Type III
2
2013
83
0.180
Why?
Female
22
2012
28792
0.180
Why?
Male
21
2012
27444
0.170
Why?
Epigenesis, Genetic
1
2004
412
0.160
Why?
Transcription Factors
1
2003
571
0.160
Why?
Antineoplastic Agents
2
2010
1232
0.150
Why?
Skin Transplantation
2
2010
43
0.150
Why?
Skin Neoplasms
4
2008
500
0.150
Why?
Carrier Proteins
4
2005
315
0.140
Why?
Tumor Suppressor Proteins
2
2011
130
0.130
Why?
Loss of Heterozygosity
2
2008
78
0.130
Why?
DNA Damage
2
2011
309
0.130
Why?
Survival Rate
3
2009
949
0.130
Why?
Neoplasm Invasiveness
4
2007
281
0.120
Why?
Graft Survival
3
2011
158
0.110
Why?
Ki-67 Antigen
2
2011
57
0.110
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
579
0.110
Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
2005
33
0.110
Why?
Algorithms
2
2008
668
0.100
Why?
Cadherins
2
2005
62
0.100
Why?
Immunoenzyme Techniques
4
2013
134
0.100
Why?
Prostatic Neoplasms
2
2008
401
0.100
Why?
Thyroid Neoplasms
2
2007
113
0.100
Why?
Keratosis
2
2003
14
0.100
Why?
Base Sequence
2
2004
620
0.090
Why?
Receptors, Cell Surface
1
2013
109
0.090
Why?
Carcinoma in Situ
2
2003
72
0.090
Why?
Lymphangioma, Cystic
1
2011
9
0.090
Why?
Laryngectomy
3
2007
27
0.090
Why?
Arteriovenous Malformations
1
2013
75
0.090
Why?
Leukoplakia, Oral
1
2011
6
0.090
Why?
Aminolevulinic Acid
1
2011
9
0.090
Why?
Endothelium, Lymphatic
1
2011
8
0.090
Why?
Lasers, Dye
1
2011
10
0.090
Why?
Cell Line, Tumor
4
2010
1470
0.090
Why?
Antigens, CD
1
2013
217
0.090
Why?
Photosensitizing Agents
1
2011
21
0.090
Why?
Wound Healing
2
2010
226
0.090
Why?
Microtubule-Associated Proteins
1
2011
61
0.090
Why?
Propranolol
1
2012
77
0.090
Why?
Lymphatic Abnormalities
1
2011
23
0.090
Why?
Photochemotherapy
1
2011
32
0.090
Why?
Biopsy
3
2011
600
0.080
Why?
Homeodomain Proteins
1
2011
81
0.080
Why?
Laser Therapy
1
2011
75
0.080
Why?
Taxoids
1
2010
38
0.080
Why?
Drug Resistance, Multiple
1
2010
25
0.080
Why?
Hemangioma
1
2012
86
0.080
Why?
Follow-Up Studies
4
2011
2318
0.080
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2010
62
0.080
Why?
Neoplasm Staging
3
2007
774
0.080
Why?
Gene Deletion
1
2011
279
0.080
Why?
Gene Expression Regulation, Neoplastic
4
2010
868
0.080
Why?
Mice, Transgenic
1
2011
561
0.070
Why?
Disease Models, Animal
2
2011
1517
0.070
Why?
Animals
8
2011
13528
0.070
Why?
Paraffin Embedding
1
2008
52
0.070
Why?
Sulfites
1
2008
2
0.070
Why?
Mice
4
2011
5982
0.070
Why?
Microsatellite Repeats
1
2008
41
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1043
0.070
Why?
Blood Glucose
1
2011
491
0.070
Why?
Neoplasm Seeding
1
2008
4
0.070
Why?
Drug Resistance, Neoplasm
1
2010
350
0.070
Why?
Chordoma
1
2008
9
0.070
Why?
Skull Base Neoplasms
1
2008
20
0.070
Why?
Recurrent Laryngeal Nerve
1
2007
12
0.070
Why?
Laryngeal Nerves
1
2007
15
0.070
Why?
Apoptosis Regulatory Proteins
2
2005
85
0.070
Why?
Receptors, Thyrotropin
1
2007
6
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2005
62
0.070
Why?
Symporters
1
2007
15
0.070
Why?
Methylation
2
2007
127
0.070
Why?
Cell Proliferation
1
2011
1031
0.070
Why?
Image Enhancement
1
2007
49
0.070
Why?
Pattern Recognition, Automated
1
2007
38
0.070
Why?
Precancerous Conditions
1
2008
87
0.060
Why?
Prostate
1
2008
118
0.060
Why?
Risk Factors
3
2008
4018
0.060
Why?
Carcinoma, Papillary
1
2007
50
0.060
Why?
Transgenes
1
2007
55
0.060
Why?
Neoplasm Recurrence, Local
2
2008
647
0.060
Why?
Image Interpretation, Computer-Assisted
1
2007
99
0.060
Why?
Cell Nucleus
1
2007
187
0.060
Why?
Child, Preschool
3
2012
4164
0.060
Why?
Child
5
2012
7384
0.060
Why?
MicroRNAs
1
2010
397
0.060
Why?
Protein Transport
1
2007
168
0.060
Why?
Syndecans
2
2003
37
0.060
Why?
RNA, Messenger
2
2007
1133
0.060
Why?
Syndecan-1
2
2003
73
0.060
Why?
Genomics
1
2008
271
0.060
Why?
Artificial Intelligence
1
2007
131
0.060
Why?
Adenomatous Polyposis Coli Protein
1
2005
3
0.060
Why?
Receptors, Atrial Natriuretic Factor
1
2005
8
0.060
Why?
Atrial Natriuretic Factor
1
2005
21
0.060
Why?
Ear, Inner
1
2005
20
0.050
Why?
Melanoma
1
2008
277
0.050
Why?
Guanine
1
2004
39
0.050
Why?
Cell Physiological Phenomena
1
2004
2
0.050
Why?
Cell Cycle Proteins
1
2005
170
0.050
Why?
Cytochromes c
1
2003
28
0.050
Why?
DNA Adducts
1
2004
79
0.050
Why?
Salivary Proteins and Peptides
1
2003
8
0.050
Why?
Statistics as Topic
1
2003
89
0.050
Why?
Isoenzymes
1
2003
165
0.050
Why?
Base Pair Mismatch
1
2003
20
0.050
Why?
Tunica Intima
1
2003
55
0.050
Why?
Adenocarcinoma, Papillary
1
2003
5
0.050
Why?
Adenocarcinoma, Follicular
1
2003
4
0.050
Why?
Adenoma, Oxyphilic
1
2003
11
0.050
Why?
Cell Count
1
2003
141
0.050
Why?
DNA-Binding Proteins
1
2005
423
0.050
Why?
Retrospective Studies
4
2007
6821
0.050
Why?
Keratoacanthoma
1
2002
7
0.040
Why?
Collagen
1
2003
215
0.040
Why?
Combined Modality Therapy
4
2004
640
0.040
Why?
Lung
1
2005
481
0.040
Why?
Molecular Sequence Data
1
2003
759
0.040
Why?
Renal Dialysis
1
2003
196
0.040
Why?
Alcohol Drinking
1
2003
241
0.040
Why?
Platelet Aggregation Inhibitors
1
2003
213
0.040
Why?
Blotting, Western
2
2013
587
0.040
Why?
Blood Platelets
1
2003
247
0.040
Why?
Cohort Studies
1
2005
1557
0.040
Why?
Adolescent
2
2012
6912
0.040
Why?
Tomography, X-Ray Computed
1
2006
1183
0.040
Why?
Prevalence
1
2004
1034
0.040
Why?
Smoking
1
2003
526
0.040
Why?
Random Allocation
2
2010
284
0.040
Why?
Quality of Life
1
2004
902
0.030
Why?
Electrophoresis, Agar Gel
2
2008
10
0.030
Why?
Sensitivity and Specificity
2
2010
869
0.030
Why?
Hyperplasia
2
2008
98
0.030
Why?
Neck Dissection
2
2008
30
0.030
Why?
Dose-Response Relationship, Drug
2
2011
1367
0.030
Why?
Fluorouracil
2
2004
59
0.030
Why?
Photosensitivity Disorders
2
2003
10
0.020
Why?
Cross-Sectional Studies
2
2012
1723
0.020
Why?
Infant
2
2012
3808
0.020
Why?
Lymph Node Excision
2
2004
132
0.020
Why?
Head
1
2013
73
0.020
Why?
Actins
1
2013
114
0.020
Why?
Neck
1
2013
97
0.020
Why?
Treatment Outcome
3
2011
5597
0.020
Why?
Lymphocele
1
2011
7
0.020
Why?
Tissue Survival
1
2011
10
0.020
Why?
Antigens, Nuclear
1
2011
23
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
46
0.020
Why?
Tissue Culture Techniques
1
2011
42
0.020
Why?
Administration, Topical
1
2011
62
0.020
Why?
Transplantation, Heterologous
1
2011
78
0.020
Why?
Time Factors
2
2010
2992
0.020
Why?
Mice, Nude
1
2011
232
0.020
Why?
Rats
2
2009
3164
0.020
Why?
Neoplasms, Squamous Cell
1
2010
7
0.020
Why?
Pharmacogenetics
1
2010
52
0.020
Why?
Granulation Tissue
1
2010
9
0.020
Why?
Tissue and Organ Harvesting
1
2010
25
0.020
Why?
Myeloid Cells
1
2010
45
0.020
Why?
Probability
1
2010
171
0.020
Why?
Endothelial Cells
1
2011
289
0.020
Why?
Carcinoma
1
2010
136
0.020
Why?
Graft Rejection
1
2010
166
0.020
Why?
Pilot Projects
1
2011
727
0.020
Why?
Thymine
1
2008
10
0.020
Why?
Neovascularization, Physiologic
1
2009
86
0.020
Why?
Chi-Square Distribution
1
2009
291
0.020
Why?
Centromere
1
2008
10
0.020
Why?
Microdissection
1
2008
20
0.020
Why?
Cell Line, Transformed
1
2008
73
0.020
Why?
Telomere
1
2008
38
0.020
Why?
Fluorescent Dyes
1
2008
90
0.020
Why?
Gene Dosage
1
2008
76
0.020
Why?
Melanocytes
1
2008
38
0.020
Why?
Genetic Markers
1
2008
104
0.020
Why?
Iodine
1
2007
12
0.020
Why?
Predictive Value of Tests
1
2010
933
0.020
Why?
Mice, Knockout
1
2010
910
0.020
Why?
Fatal Outcome
1
2008
193
0.020
Why?
Cluster Analysis
1
2007
238
0.020
Why?
Epithelial Cells
1
2008
218
0.020
Why?
Prospective Studies
1
2011
2412
0.010
Why?
Round Window, Ear
1
2005
7
0.010
Why?
Buffers
1
2005
12
0.010
Why?
Rats, Sprague-Dawley
1
2009
1544
0.010
Why?
Rats, Inbred Lew
1
2005
50
0.010
Why?
Injections
1
2005
59
0.010
Why?
Phosphates
1
2005
51
0.010
Why?
Sodium Chloride
1
2005
53
0.010
Why?
Protein Isoforms
1
2005
124
0.010
Why?
Mice, Inbred C57BL
1
2010
1925
0.010
Why?
Drug Combinations
1
2005
138
0.010
Why?
Antibodies
1
2005
147
0.010
Why?
Reproducibility of Results
1
2007
1221
0.010
Why?
Statistics, Nonparametric
1
2004
198
0.010
Why?
Disease-Free Survival
1
2005
466
0.010
Why?
Platelet Adhesiveness
1
2003
15
0.010
Why?
Up-Regulation
1
2005
456
0.010
Why?
Polytetrafluoroethylene
1
2003
33
0.010
Why?
Elastin
1
2003
24
0.010
Why?
DNA Primers
1
2003
202
0.010
Why?
Radiotherapy
1
2004
126
0.010
Why?
Anastomosis, Surgical
1
2003
69
0.010
Why?
Vascular Patency
1
2003
88
0.010
Why?
Dogs
1
2003
186
0.010
Why?
Radiotherapy, Adjuvant
1
2003
65
0.010
Why?
Myocytes, Smooth Muscle
1
2003
96
0.010
Why?
Chemotherapy, Adjuvant
1
2003
122
0.010
Why?
Extracellular Matrix
1
2003
116
0.010
Why?
Graft Occlusion, Vascular
1
2003
81
0.010
Why?
Thyroidectomy
1
2003
61
0.010
Why?
Biopsy, Needle
1
2003
181
0.010
Why?
Lymphatic Metastasis
1
2003
211
0.010
Why?
Young Adult
1
2012
4514
0.010
Why?
Stromal Cells
1
2002
77
0.010
Why?
Models, Biological
1
2003
737
0.010
Why?
Diagnosis, Differential
1
2002
1038
0.010
Why?
Risk Assessment
1
2003
1368
0.010
Why?
Arkansas
1
2004
2068
0.010
Why?
Pregnancy
1
2003
2610
0.010
Why?
Fan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description